Global Orphan Diseases Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 90

Report ID: 1437

An orphan disease is defined as a condition that affects fewer than 200,000 people nationwide. This includes diseases as familiar as cystic fibrosis, Lou Gehrig's disease, and Tourette's syndrome, and as unfamiliar as Hamburger disease, Job syndrome, and acromegaly, or "gigantism." Some diseases have patient populations of fewer than a hundred.
New rare diseases are discovered every year. Most are inherited and caused by alterations or defects in genes (mutations). Others can be acquired as a result of environmental and toxic conditions. Genes are pieces of DNA, part of the code that determines the traits and individual characteristics of all living things.
In 2018, the global Orphan Diseases market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Orphan Diseases status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Orphan Diseases development in United States, Europe and China.

The key players covered in this study
Bristol-Myers Squibb
Novartis
Celgene
Roche
Pfizer
Alexion
Sanofi
Vertex Pharmaceuticals
GlaxoSmithKline
Merck
Abbvie

Market segment by Type, the product can be split into
Autoimmune Disorders
Genetic Disorders
Blood Disorders
Cancer
Growth Disorder
Cardiovascular Diseases
Neurological Disorders
Respiratory Disorders
Digestive Disorders
Eye Disorders

Market segment by Application, split into
Hospitals And Clinics
Research Laboratories

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Orphan Diseases status, future forecast, growth opportunity, key market and key players.
To present the Orphan Diseases development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Orphan Diseases are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Orphan Diseases Market Size Growth Rate by Type (2014-2025)
1.4.2 Autoimmune Disorders
1.4.3 Genetic Disorders
1.4.4 Blood Disorders
1.4.5 Cancer
1.4.6 Growth Disorder
1.4.7 Cardiovascular Diseases
1.4.8 Neurological Disorders
1.4.9 Respiratory Disorders
1.4.10 Digestive Disorders
1.4.11 Eye Disorders
1.5 Market by Application
1.5.1 Global Orphan Diseases Market Share by Application (2014-2025)
1.5.2 Hospitals And Clinics
1.5.3 Research Laboratories
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Orphan Diseases Market Size
2.2 Orphan Diseases Growth Trends by Regions
2.2.1 Orphan Diseases Market Size by Regions (2014-2025)
2.2.2 Orphan Diseases Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Orphan Diseases Market Size by Manufacturers
3.1.1 Global Orphan Diseases Revenue by Manufacturers (2014-2019)
3.1.2 Global Orphan Diseases Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Orphan Diseases Market Concentration Ratio (CR5 and HHI)
3.2 Orphan Diseases Key Players Head office and Area Served
3.3 Key Players Orphan Diseases Product/Solution/Service
3.4 Date of Enter into Orphan Diseases Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Orphan Diseases Market Size by Type (2014-2019)
4.2 Global Orphan Diseases Market Size by Application (2014-2019)

5 United States
5.1 United States Orphan Diseases Market Size (2014-2019)
5.2 Orphan Diseases Key Players in United States
5.3 United States Orphan Diseases Market Size by Type
5.4 United States Orphan Diseases Market Size by Application

6 Europe
6.1 Europe Orphan Diseases Market Size (2014-2019)
6.2 Orphan Diseases Key Players in Europe
6.3 Europe Orphan Diseases Market Size by Type
6.4 Europe Orphan Diseases Market Size by Application

7 China
7.1 China Orphan Diseases Market Size (2014-2019)
7.2 Orphan Diseases Key Players in China
7.3 China Orphan Diseases Market Size by Type
7.4 China Orphan Diseases Market Size by Application

8 Japan
8.1 Japan Orphan Diseases Market Size (2014-2019)
8.2 Orphan Diseases Key Players in Japan
8.3 Japan Orphan Diseases Market Size by Type
8.4 Japan Orphan Diseases Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Orphan Diseases Market Size (2014-2019)
9.2 Orphan Diseases Key Players in Southeast Asia
9.3 Southeast Asia Orphan Diseases Market Size by Type
9.4 Southeast Asia Orphan Diseases Market Size by Application

10 India
10.1 India Orphan Diseases Market Size (2014-2019)
10.2 Orphan Diseases Key Players in India
10.3 India Orphan Diseases Market Size by Type
10.4 India Orphan Diseases Market Size by Application

11 Central & South America
11.1 Central & South America Orphan Diseases Market Size (2014-2019)
11.2 Orphan Diseases Key Players in Central & South America
11.3 Central & South America Orphan Diseases Market Size by Type
11.4 Central & South America Orphan Diseases Market Size by Application

12 International Players Profiles
12.1 Bristol-Myers Squibb
12.1.1 Bristol-Myers Squibb Company Details
12.1.2 Company Description and Business Overview
12.1.3 Orphan Diseases Introduction
12.1.4 Bristol-Myers Squibb Revenue in Orphan Diseases Business (2014-2019)
12.1.5 Bristol-Myers Squibb Recent Development
12.2 Novartis
12.2.1 Novartis Company Details
12.2.2 Company Description and Business Overview
12.2.3 Orphan Diseases Introduction
12.2.4 Novartis Revenue in Orphan Diseases Business (2014-2019)
12.2.5 Novartis Recent Development
12.3 Celgene
12.3.1 Celgene Company Details
12.3.2 Company Description and Business Overview
12.3.3 Orphan Diseases Introduction
12.3.4 Celgene Revenue in Orphan Diseases Business (2014-2019)
12.3.5 Celgene Recent Development
12.4 Roche
12.4.1 Roche Company Details
12.4.2 Company Description and Business Overview
12.4.3 Orphan Diseases Introduction
12.4.4 Roche Revenue in Orphan Diseases Business (2014-2019)
12.4.5 Roche Recent Development
12.5 Pfizer
12.5.1 Pfizer Company Details
12.5.2 Company Description and Business Overview
12.5.3 Orphan Diseases Introduction
12.5.4 Pfizer Revenue in Orphan Diseases Business (2014-2019)
12.5.5 Pfizer Recent Development
12.6 Alexion
12.6.1 Alexion Company Details
12.6.2 Company Description and Business Overview
12.6.3 Orphan Diseases Introduction
12.6.4 Alexion Revenue in Orphan Diseases Business (2014-2019)
12.6.5 Alexion Recent Development
12.7 Sanofi
12.7.1 Sanofi Company Details
12.7.2 Company Description and Business Overview
12.7.3 Orphan Diseases Introduction
12.7.4 Sanofi Revenue in Orphan Diseases Business (2014-2019)
12.7.5 Sanofi Recent Development
12.8 Vertex Pharmaceuticals
12.8.1 Vertex Pharmaceuticals Company Details
12.8.2 Company Description and Business Overview
12.8.3 Orphan Diseases Introduction
12.8.4 Vertex Pharmaceuticals Revenue in Orphan Diseases Business (2014-2019)
12.8.5 Vertex Pharmaceuticals Recent Development
12.9 GlaxoSmithKline
12.9.1 GlaxoSmithKline Company Details
12.9.2 Company Description and Business Overview
12.9.3 Orphan Diseases Introduction
12.9.4 GlaxoSmithKline Revenue in Orphan Diseases Business (2014-2019)
12.9.5 GlaxoSmithKline Recent Development
12.10 Merck
12.10.1 Merck Company Details
12.10.2 Company Description and Business Overview
12.10.3 Orphan Diseases Introduction
12.10.4 Merck Revenue in Orphan Diseases Business (2014-2019)
12.10.5 Merck Recent Development
12.11 Abbvie

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details